Your browser doesn't support javascript.
loading
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.
Ho, Kai-Wen; Chen, I-J U; Cheng, Yi-An; Liao, Tzu-Yi; Liu, En-Shuo; Chen, Huei-Jen; Lu, Yun-Chi; Su, Yu-Cheng; Roffler, Steve R; Huang, Bo-Cheng; Liu, Hui-Ju; Huang, Ming-Yii; Chen, Chiao-Yun; Cheng, Tian-Lu.
Afiliação
  • Ho KW; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Chen IU; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Cheng YA; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, No. 100 Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan.
  • Liao TY; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Liu ES; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Chen HJ; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, No. 100 Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan.
  • Lu YC; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Su YC; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Roffler SR; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, No. 100 Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan.
  • Huang BC; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Liu HJ; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Huang MY; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Chen CY; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Cheng TL; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
J Nanobiotechnology ; 19(1): 16, 2021 Jan 09.
Article em En | MEDLINE | ID: mdl-33422061
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Leucemia / Doxorrubicina / Anticorpos Biespecíficos / Anticorpos de Cadeia Única Limite: Animals / Female / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Leucemia / Doxorrubicina / Anticorpos Biespecíficos / Anticorpos de Cadeia Única Limite: Animals / Female / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan